Anti-EIF2B2 antibodies are used in the immunodetection of the protein eukaryotic translation initiation factor 2B subunit beta. In humans, the canonical protein has a reported length of 351 amino acid residues and a mass of 39 kDa. It is notably widely expressed in many tissue types. A member of the EIF-2B alpha/beta/delta subunits protein family, EIF2B2 is known to catalyze the exchange of eukaryotic initiation factor 2-bound GDP for GTP. The EIF2B2 gene has been associated with the disease, Leukodystrophy with vanishing white matter. Synonyms for this target antigen include EIF2B, VWM2, translation initiation factor eIF-2B subunit beta, S20I15, and EIF-2Bbeta. EIF2B2 gene orthologs have been reported in the mouse, rat, bovine, frog, zebrafish, chimpanzee and chicken species. A number of EIF2B2 antibodies have been mentioned in research publications and have associated citations. Western Blot is a widely used application for these antibodies. ELISA and Immunohistochemistry are also common applications.